Emergent to make Providence Therapeutics potential COVID-19 vaccine

Emergent to make Providence Therapeutics potential COVID-19 vaccine

A woman holds a test tube in front of displayed Emergent logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/IllustrationSept 14 (Reuters) – Emergent BioSolutions Inc (EBS.N) signed a five-year agreement with Canadian biotechnology company Providence Therapeutics to develop and manufacture its COVID-19 vaccine candidate for about $90 million.Emergent will produce drug substances for … Read more